This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD83, based on 18 published articles (read how Labome selects the articles), using CD83 antibody in all methods. It is aimed to help Labome visitors find the most suited CD83 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD83 synonym: CD83 antigen
BioLegend
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples (fig 1b). Front Immunol (2018) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (Biolegend, HB15e) was used in flow cytometry on human samples (fig 8a). Nat Commun (2018) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, 305307) was used in flow cytometry on human samples at 1:100 (fig s2a). Nat Commun (2018) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples (fig 8c). elife (2017) ncbi |
mouse monoclonal (HB15e) |
| In order to map the lineage of human dendritic cells, BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples (fig 5b). Science (2017) ncbi |
mouse monoclonal (HB15e) |
| In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples . MBio (2017) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, 305312) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (Biolegend, HB15e) was used in flow cytometry on human samples (fig 7b). J Biol Chem (2016) ncbi |
mouse monoclonal (HB15e) |
| In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend CD83 antibody (BioLegend, HB15E) was used in immunocytochemistry on human samples (fig s3b). J Allergy Clin Immunol (2016) ncbi |
mouse monoclonal (HB15e) |
| In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi |
mouse monoclonal (HB15e) |
| In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend CD83 antibody (Biolegend, 305305) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (Biolegend, HB15e) was used in flow cytometry on human samples (fig 1b). J Immunol Res (2015) ncbi |
mouse monoclonal (HB15e) |
| In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD83 antibody (Biolegend, HB15e) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, HB 15e) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi |
mouse monoclonal (HB15e) |
| BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi |
mouse monoclonal (HB15e) |
| In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD83 antibody (BioLegend, HB15e) was used in flow cytometry on human samples (fig 2a). J Leukoc Biol (2014) ncbi |
Bio-Rad
mouse monoclonal (HB15e) |
| Bio-Rad CD83 antibody (Serotec, MCA1582) was used in immunohistochemistry - paraffin section on Tasmanian devil samples at 1:80. Anat Rec (Hoboken) (2014) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments